Clinical Trial Update: Cognitive Assessment Battery (CAB) Beta Study

View source ↗

Summary

This trial update reports that the Cognitive Assessment Battery (CAB) Beta Study for Huntington's disease has completed, sponsored by CHDI Foundation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: CHDI Foundation, Inc. | Conditions: Huntington's Disease | Status: COMPLETED